-+ 0.00%
-+ 0.00%
-+ 0.00%

Market news: Bayntech announced the progress of the advanced lung cancer pipeline at the 2026 World Lung Cancer Conference, revealing the first batch of global clinical data on the new dual novel combination of Pumitamig and Elfetabart Drozuntecan.

Zhitongcaijing·08/20/2026 09:33:19
Listen to the news
Market news: Bayntech announced the progress of the advanced lung cancer pipeline at the 2026 World Lung Cancer Conference, revealing the first batch of global clinical data on the new dual novel combination of Pumitamig and Elfetabart Drozuntecan.